Last reviewed · How we verify
NCT04063397: ECHO
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
trial testing Echocardiogram in Preeclampsia Severe or Mild in 27 participants. Completed in 14 December 2023.
30 January 2023
Quick facts
| Lead sponsor | Ohio State University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 27 |
| Start date | 19 August 2019 |
| Primary completion | 30 January 2023 |
| Estimated completion | 14 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Echocardiogram
- Blood draw — full drug profile →
Conditions studied
- Preeclampsia Severe or Mild — all drugs for Preeclampsia Severe or Mild →
- Cardiac Complication — all drugs for Cardiac Complication →
Sponsor
Ohio State University
Who can join
18 and older, female only, with Preeclampsia Severe or Mild or Cardiac Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evaluation at several time points. With the current proposal, the investigators aim to collect blood to evaluate several biomarkers to determine if there is a correlation with short and medium-term cardiovascular risk. This opens the door to earlier detection, treatment and improved cardiovascular outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04063397
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Echocardiogram
Trials testing the same drug.
- NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
- NCT07058064 — WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring) · NA · recruiting
- NCT06927973 — Leveraging Exercise Stress Echocardiography for Heart Failure With Preserved Ejection Fraction · NA · completed
- NCT07132788 — Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass · active not recruiting
- NCT06622928 — Ventriculo-Arterial Coupling and Intra-Dialytic Changes in Hemodialysis Patients: Prognostic Insights · not yet recruiting
Other Ohio State University trials
Trials by the same sponsor.
- NCT06542458 — Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog · not yet recruiting
- NCT07217548 — Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients · NA · enrolling by invitation
- NCT07215221 — Implementation of TBI-RECOVER in Substance Use Treatment · NA · not yet recruiting
- NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
- NCT07490444 — Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04063397 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ohio State University
- Last refreshed: 10 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04063397.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing